Filing Details

Accession Number:
0001140361-13-010902
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-06 11:18:27
Reporting Period:
2013-03-04
Filing Date:
2013-03-06
Accepted Time:
2013-03-06 11:18:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1159019 Tribute Pharmaceuticals Canada Inc. TBUFF Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1200376 M John Gregory 340 Martin Luther King, Jr. Blvd.
Suite 200
Bristol TN 37620
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2013-03-04 625,000 $0.00 625,000 No 4 P Direct
Common Shares Acquisiton 2013-03-04 1,250,000 $0.00 6,438,794 No 4 P Indirect Affiliate
Common Shares Acquisiton 2013-03-04 625,000 $0.00 1,025,000 No 4 P Indirect Kingsway Charities
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect Affiliate
No 4 P Indirect Kingsway Charities
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Common Stock Warrants (right to buy) Acquisiton 2013-03-04 312,500 $0.00 312,500 $0.50
Common Stock Series B Common Stock Warrants (right to buy) Acquisiton 2013-03-04 312,500 $0.00 312,500 $0.60
Common Stock Series A Common Stock Warrants (right to buy) Acquisiton 2013-03-04 625,000 $0.00 625,000 $0.50
Common Stock Series B Common Stock Warrants (right to buy) Acquisiton 2013-03-04 625,000 $0.00 625,000 $0.60
Common Stock Series A Common Stock Warrants (right to buy) Acquisiton 2013-03-04 312,500 $0.00 312,500 $0.50
Common Stock Series B Common Stock Warrants (right to buy) Acquisiton 2013-03-04 312,500 $0.00 312,500 $0.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
312,500 2013-03-04 2015-03-04 No 4 P Direct
312,500 2013-03-04 2018-03-04 No 4 P Direct
625,000 2013-03-04 2015-03-04 No 4 P Indirect
625,000 2013-03-04 2018-03-04 No 4 P Indirect
312,500 2013-03-04 2015-03-04 No 4 P Indirect
312,500 2013-03-04 2018-03-04 No 4 P Indirect
Footnotes
  1. The reported securities are included within Units purchased by the reporting person for $0.40 per Unit. Each Unit consists of one share of common stock, a Series A Warrant to purchase 1/2 a share of common stock, and a Series B Warrant to purchase 1/2 a share of common stock.